• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Anika Therapeutics (NQ: ANIK )

    16.53 -0.58 (-3.39%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Anika Therapeutics

    < Previous 1 2 Next >
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    What's Next: Anika Therapeutics's Earnings Preview
    Via Benzinga
    ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024
    ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
    Via Benzinga
    ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024
    ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Anika Therapeutics: Q4 Earnings Insights
    Via Benzinga
    Earnings Outlook For Anika Therapeutics
    Via Benzinga
    Recap: Anika Therapeutics Q1 Earnings
    Via Benzinga
    Anika Therapeutics Earnings Preview
    Via Benzinga
    New FDA 510(k) Clearance Expands Anika's Sports Medicine Soft Tissue Portfolio
    Via Benzinga
    Earnings Scheduled For March 13, 2024
    Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million. 
    Via Benzinga
    Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
    ABNB and BX will join Sept. 18 as part of a quarterly rebalancing. 
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    Stocks That Hit 52-Week Lows On Friday
    During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest... 
    Via Benzinga
    3 Sorry Penny Stocks to Sell in August Before It’s Too Late
    As interest rates rise and money becomes more expensive, investors may look to get rid of these penny stocks set to fail. 
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... 
    Via Benzinga
    7 Stocks to Buy Before the Market Starts to Soar in 2023
    With the market falling into a bit of disarray, astute investors can leverage this moment to dive into compelling stocks to buy. 
    Via InvestorPlace
    Anika Therapeutics Cingal Tops Steroid For Osteoarthritis Pain Relief
    Via Benzinga
    Anika Therapeutics: Q2 Earnings Insights
    Anika Therapeutics (NASDAQ:ANIK) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    During Wednesday's session, 35 companies made new 52-week lows. 52-Week High And Low Highlights: The company with the largest market cap to set a new 52-week low was... 
    Via Benzinga
    Anika Therapeutics: Q4 Earnings Insights
    Anika Therapeutics (NASDAQ:ANIK) reported its Q4 earnings results on Tuesday, March 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings... 
    Via Benzinga
    The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... 
    Via Benzinga
    Anika Therapeutics, inc (ANIK) Q3 2021 Earnings Call Transcript
    ANIK earnings call for the period ending September 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Return on Capital Employed Insights for Anika Therapeutics
    After pulling data from Benzinga Pro it seems like during Q2, Anika Therapeutics (NASDAQ:ANIK) earned $9.18 million, a 629.73% increase from the preceding quarter. Anika... 
    Via Benzinga
    Anika Therapeutics, inc (ANIK) Q2 2021 Earnings Call Transcript
    ANIK earnings call for the period ending June 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Earnings Scheduled For March 8, 2022
    Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •... 
    Via Benzinga
    The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
    Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2021
    Upgrades According to Maxim Group, the prior rating for VirTra Inc (NASDAQ: 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.